Researchers develop a way to grow and genetically engineer the progenitor cells that give rise to macrophages, a type of first-responder immune cell that shows promise for developing immunotherapies for cancers and other diseases. The post USC-led team creates renewable cell source for cancer immunotherapy and beyond appeared first on USC .